Peer‑Reviewed Study Confirms ABL Diagnostics’ CE‑IVD Whole‑Genome HIV‑1 Assay as a Global First

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...
University at Buffalo

UB researchers help develop new class of powerful antibodies to treat HIV using AI

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical ...
WVXU

HIV advocates, organizations talk legislative solutions at first advocacy summit

Carrie Foote, who leads HIV Modernization Movement-Indiana, said HIV criminalization laws lead to stigma that acts as a barrier to testing and care. And that gets in the way of preventing new ...

GLAAD's ‘Generation Z & HIV: HBCU Tour' heads to Morehouse College

The push for HIV awareness among Generation Z continues as GLAAD brings its "Generation Z & HIV: Human Issue and Southern ...
KRON4 News

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ® ...
Business Insider

Institute for Policy Solutions at Johns Hopkins School of Nursing: Urgent New Approaches Needed to End HIV/AIDS Crisis Among Latinos

New Paper in New England Journal of Medicine Calls for Health Care Community to Help End Latino HIV Crisis, Outlines Comprehensive Approach and Blueprint for Action. WASHINGTON, DC / ACCESSWIRE / ...
WSIL-TV

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately.